Sumitomo Pharma Co., Ltd., July-September (2Q) Net Income Loss Widens

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Wed Oct 30, 2024 1:30 pm JST Earnings

4506 Sumitomo Pharma Co., Ltd. 【IFRS】

Earnings Report

Sumitomo Pharma Co., Ltd. <4506> [TSE-P] announced its financial results (based on IFRS) in the afternoon session on October 30th (13:30). The consolidated net loss for the cumulative second quarter of the fiscal year ending March 2025 (April to September) was a reduced loss of 32.2 billion yen (compared to a loss of 67.7 billion yen in the same period last year).

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated net income/loss for the October to March period (second half) is expected to turn into a profit of 16.2 billion yen (compared to a loss of 247 billion yen in the same period last year).

In the most recent three-month period, from July to September (2Q), the consolidated net loss expanded to a loss of 48.1 billion yen (compared to a loss of 28.8 billion yen in the same period last year). However, the operating profit/loss margin drastically improved from -45.4% in the same period last year to -5.6%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Progress Rate vs. First Half	Announce	Accounting Standards
Apr - Sep, 2022	319,289	-28,915	21,034	-7,283	-18.3	ー	Oct 31, 2022	IFRS
Apr - Sep, 2023	152,642	-86,498	-56,127	-67,741	-170.5	ー	Oct 31, 2023	IFRS
Apr - Sep, 2024	180,749	-8,179	-32,406	-32,229	-81.1	ー	Oct 30, 2024	IFRS
YoY	+18.4%	+90.5%	+42.3%	+52.4%	+52.4%

First Half Results vs. Previous Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Apr - Sep, 2024 Guidance	ー	ー	ー	ー	－	0	May 14, 2024	IFRS
Apr - Sep, 2024 Results	180,749	-8,179	-32,406	-32,229	-81.1	0	Oct 30, 2024	IFRS
Revision Rate	－	－	－	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	161,916	-268,361	-266,987	-247,228	-622.3	0	May 14, 2024	IFRS
Oct - Mar, 2024 Guidance	157,251	8,179	ー	16,229	40.9	0	Oct 30, 2024	IFRS
YoY	-2.9%	－	－	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	555,544	-76,979	-47,920	-74,512	-187.6	21	May 15, 2023	IFRS
Mar, 2024	314,558	-354,859	-323,114	-314,969	-792.8	0	May 14, 2024	IFRS
Mar, 2025 Guidance	338,000	0	ー	-16,000	-40.3	0	May 14, 2024	IFRS
YoY	+7.5%	－	－	+94.9%	+94.9%

Quarterly Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Operating Profit Margin	Announce	Accounting Standards
Jul - Sep, 2023	76,956	-34,931	-25,075	-28,876	-72.7	-45.4	Oct 31, 2023	IFRS
Oct - Dec, 2023	82,386	-31,247	-49,064	-49,967	-125.8	-37.9	Jan 31, 2024	IFRS
Jan - Mar, 2024	79,530	-237,114	-217,923	-197,261	-496.5	-298.1	May 14, 2024	IFRS
Apr - Jun, 2024	90,675	-3,105	17,203	15,937	40.1	-3.4	Jul 31, 2024	IFRS
Jul - Sep, 2024	90,074	-5,074	-49,609	-48,166	-121.2	-5.6	Oct 30, 2024	IFRS
YoY	+17.0%	+85.5%	-97.8%	-66.8%	-66.8%